Ex-FTC Official Pans Claim Gilead-Teva Deal Hurt Competition
Law 360
JUNE 23, 2023
California federal jurors considering claims that pharmaceutical companies Gilead Sciences Inc. and Teva Pharmaceutical Industries Ltd.
companies gilead-sciences-inc 
52 
Gilead Sues To Reclaim Convicted Ex-CFO's $4M Legal Fees
Law 360
NOVEMBER 3, 2023
Gilead Sciences Inc. on Friday asked a Delaware state court to force a former executive to cough up the $4 million the biotech company racked up during the U.S. Department of Justice's insider trading investigation into him, saying it isn't obligated to cover those costs now that he's been convicted.
Join 105,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Gilead Must Foot $1.8M Bill For 'Egregious' Litigation Conduct
Law 360
JULY 22, 2021
The Delaware chancellor on Thursday chastised Gilead Sciences Inc. for "glaringly egregious" litigation conduct, ordering the company to pay nearly $1.76
Centene Hits Gilead With HIV Generic Antitrust Suit
Law 360
DECEMBER 15, 2021
Managed care company Centene Corp. has hit Gilead Sciences Inc.
Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 2)
FDA Law Blog
FEBRUARY 29, 2024
Drug companies are still required to conduct studies to confirm the anticipated clinical benefit. On April 14, 2023, the PTO issued an ORDER TO SHOW CAUSE to Eli Lilly and Company (“Lilly”) “based on the apparent ineligibility of U.S. From there, the PTO conveys the same message to Gilead as it did to Glaxo and Lilly above.
Let's personalize your content